| Phase 3 |
| NCT06532006 |
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for… |
Gastroesophageal-junction Cancer |
Recruiting |
2026-02-27 |
| NCT05353257 |
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With… |
Limited-Stage Small Cell Lung Cancer |
Active, Not Recruiting |
2026-01-13 |
| NCT05468489 |
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in… |
Extensive Stage Small Cell Lung Cancer |
Active, Not Recruiting |
2025-10-21 |
| NCT05346224 |
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant… |
Breast Cancer |
Active, Not Recruiting |
2025-06-10 |
| NCT06895512 |
A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination… |
Newly Diagnosed Multiple Myeloma |
Not Yet Recruiting |
2025-03-26 |
| NCT06847334 |
A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of… |
Non-Squamous Non-Small Cell Lung Cancer |
Not Yet Recruiting |
2025-02-26 |
| NCT06841185 |
A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of… |
Hepatocellular Carcinoma (HCC) |
Not Yet Recruiting |
2025-02-24 |
| NCT04301739 |
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo… |
Triple Negative Breast Cancer |
Not Yet Recruiting |
2020-03-12 |
| Phase 2/3 |
| NCT07459751 |
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43… |
Advanced or Metastatic Squamous Non-Small Cell Lung Cancer |
Recruiting |
2026-06-01 |
| NCT07294508 |
A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive… |
HER2 + Breast Cancer |
Recruiting |
2026-03-20 |
| NCT04547166 |
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With… |
Metastatic Colorectal Cancer |
Recruiting |
2024-10-17 |
| NCT07318883 |
A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and… |
Squamous NSCLC |
Not Yet Recruiting |
2026-01-06 |
| NCT07294534 |
A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination… |
HER2 + Breast Cancer |
Not Yet Recruiting |
2025-12-19 |
| Phase 2 |
| NCT06907615 |
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung… |
Non Small Cell Lung Cancer |
Recruiting |
2026-10-01 |
| NCT07253142 |
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects… |
Non Small Cell Lung Cancer |
Recruiting |
2026-07-21 |
| NCT07269782 |
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as… |
Non Small Cell Lung Cancer |
Recruiting |
2026-06-04 |
| NCT06769113 |
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC… |
Esophageal Cancer |
Recruiting |
2026-05-18 |
| NCT06769152 |
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC)… |
Cervical Cancer |
Recruiting |
2026-04-22 |
| NCT06857279 |
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head… |
Carcinoma of Head and/or Neck |
Recruiting |
2026-03-05 |
| NCT06839066 |
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal… |
Nasopharyngeal Carcinoma (NPC) |
Recruiting |
2025-11-24 |
| NCT07038382 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion… |
Membranous Nephropathy |
Recruiting |
2025-11-18 |
| NCT07115485 |
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an… |
Gastric or Gastroesophageal Junction Adenocarcinoma |
Recruiting |
2025-11-18 |
| NCT07106892 |
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an… |
Colorectal Cancer (CRC) |
Recruiting |
2025-11-17 |
| NCT06832202 |
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone… |
HER2-low Hormone Receptor Positive Breast Cancer |
Recruiting |
2025-06-15 |
| NCT06742892 |
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or… |
Carcinoma, Hepatocellular |
Recruiting |
2025-03-10 |